Biotechnology & Pharmaceutical Services Outsourcing Market (By Services: Services, Auditing and Assessment, Regulatory Affairs, Others; By Services Outsourcing: Pharma and Biotech) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biotechnology and Pharmaceutical Services Outsourcing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services Type, 2023-2032
8.1.1. Consulting
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Auditing and Assessment
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Regulatory Affairs
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
9.1. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services Outsourcing, 2023-2032
9.1.1. Pharma
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Biotech
9.1.2.1. Market Revenue and Forecast (2020-2032)
10.1. North America
10.1.1. Market Revenue and Forecast, by Services (2020-2032)
10.1.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Services (2020-2032)
10.1.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Services (2020-2032)
10.1.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Services (2020-2032)
10.2.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Services (2020-2032)
10.2.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Services (2020-2032)
10.2.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Services (2020-2032)
10.2.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Services (2020-2032)
10.2.6.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Services (2020-2032)
10.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Services (2020-2032)
10.3.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Services (2020-2032)
10.3.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Services (2020-2032)
10.3.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Services (2020-2032)
10.3.6.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Services (2020-2032)
10.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Services (2020-2032)
10.4.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Services (2020-2032)
10.4.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Services (2020-2032)
10.4.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Services (2020-2032)
10.4.6.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Services (2020-2032)
10.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Services (2020-2032)
10.5.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Services (2020-2032)
10.5.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)
11.1. ICON Plc
11.1.1. Company Overview
11.1.2. Product Offering
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. The Quantic Group
11.2.1. Company Overview
11.2.2. Product Offering
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Covance Inc.
11.3.1. Company Overview
11.3.2. Product Offering
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. PFA Health Sciences
11.4.1. Company Overview
11.4.2. Product Offering
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. IQVIA Holdings Inc.
11.5.1. Company Overview
11.5.2. Product Offering
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Lachman Consultant Services
11.6.1. Company Overview
11.6.2. Product Offering
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Charles River
11.7.1. Company Overview
11.7.2. Product Offering
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Parexel International Corporation
11.8.1. Company Overview
11.8.2. Product Offering
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. GMP Pharmaceuticals
11.9.1. Company Overview
11.9.2. Product Offering
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Concept Heidelberg GmbH
11.10.1. Company Overview
11.10.2. Product Offering
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample